{"url":"https://lda.gov/api/v1/filings/1d14b966-b7ca-4829-9045-3896deb0e33a/","filing_uuid":"1d14b966-b7ca-4829-9045-3896deb0e33a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1d14b966-b7ca-4829-9045-3896deb0e33a/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Bryant Hall, President","dt_posted":"2025-04-17T15:22:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400712135,"url":"https://lda.gov/api/v1/registrants/400712135/","house_registrant_id":null,"name":"TIBER CREEK HEALTH STRATEGIES, INC.","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHON JONES","contact_telephone":"+1 202-775-8116","dt_updated":"2026-07-20T13:08:01.259800-04:00"},"client":{"id":194536,"url":"https://lda.gov/api/v1/clients/194536/","client_id":24,"name":"AMGEN, INC.","general_description":"Biotechnology company.","client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-01-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issue related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54797,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"BRYANT","last_name":"HALL","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}